Results 221 to 230 of about 101,810 (380)
Schematic representation of the distinct tumor microenvironment characteristics in CA1 and CA2 subtypes. CA1 illustrates an immune‐active tumor microenvironment characterized by elevated infiltration of immune cells, particularly CD8 + T cells and macrophages, and enhanced IFN‐γ signaling.
Shuting Xia +14 more
wiley +1 more source
Research and development financing models for new biopharmaceuticals in the United States. [PDF]
Kang SY +4 more
europepmc +1 more source
Color Flow Imaging Microscopy Improves Identification of Stress Sources of Protein Aggregates in Biopharmaceuticals [PDF]
Michaela Cohrs +6 more
openalex +1 more source
Abstract BACKGROUND Selecting an optimal chromatography resin during biopharmaceutical downstream process development is a great challenge. This is especially the case for recombinant subunit vaccines, where product properties vary greatly and recovery often involves cell lysis, which yields a complex mixture of different host cell materials. Host cell
Tim Neijenhuis +4 more
wiley +1 more source
Physics-based surface patch analysis for prediction of hydrophobic contribution to viscosity of mAbs. [PDF]
Knez B, Ravnik M, Zidar M.
europepmc +1 more source
Sample Management and Factors to be Considered for Biopharmaceutical Characterisation
Amisha Mahesh Bhopatrao +1 more
openalex +1 more source
Cysteine Reactivity Profiling Illuminates Monoclonal Antibody Disulfide Bond Reduction Mechanisms in Biopharmaceutical Process Intermediates [PDF]
Taku Tsukidate +4 more
openalex +1 more source
Abstract BACKGROUND Napin and cruciferin, the predominant storage proteins in Brassica napus (rapeseed), exhibit favorable techno‐functional properties such as emulsification and gel formation, positioning them as promising candidates for the encapsulation and delivery of bioactive compounds. Their classification as GRAS (Generally Recognized As Safe),
Jonas Arnecke +4 more
wiley +1 more source
Models attempting to quantify the relationship between drug development and financial return are missing a key element: the effect on post-approval research. [PDF]
Crippen D, Axelsen K.
europepmc +1 more source

